The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling

被引:97
作者
Gáborik, Z
Jagadeesh, G
Zhang, M
Spät, A
Catt, KJ
Hunyady, L
机构
[1] Semmelweis Univ, Fac Med, Dept Physiol, H-1088 Budapest, Hungary
[2] Semmelweis Univ, Fac Med, Lab Cellular & Mol Physiol, H-1088 Budapest, Hungary
[3] NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA
[4] US FDA, Div Cardiorenal Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
关键词
D O I
10.1210/en.2002-0135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pleiotropic actions of angiotensin II are mediated by the primarily G. protein-coupled type I angiotensin (AT(1)) receptor. In this study a mutational analysis of the function of the conserved DRYXXV/IXKPL domain in the second intracellular loop of the rat AT(1A) receptor was performed in COS7 cells. Alanine substitution studies showed that single replacement of the highly conserved Asp(125) and Arg(126), but not Tyr(127), moderately impaired angiotensin II-induced inositol phosphate signaling. However, concomitant substitution of both Asp(125) and Arg(126) caused marked reduction of both inositol phosphate signaling and receptor internalization. Alanine scanning of the adjacent residues showed that substitution of Ile(130), His(132), and Pro(133) reduced agonist-induced inositol phosphate signal generation, whereas mutations of Met(134) also impaired receptor internalization. Expression of the D125A mutant AT(1A) receptor in COS7 cells endowed the receptor with moderate constitutive activity, as indicated by its enhanced basal Elk1 promoter activity and inositol phosphate response to partial agonists. Angiotensin II- induced stimulation of the Elk1 promoter showed parallel impairment with inositol phosphate signal generation in receptors containing mutations in this region of the AT(1A) receptor. These data confirm that Ca2+ signal generation is required for the nuclear effects of angiotensin II-induced ERR activation. They are also consistent with the role of the conserved DRY sequence of the AT(1A) receptor in receptor activation, and of Asp(125) in constraining the receptor in its inactive conformation. Furthermore, in the cytoplasmic helical extension of the third helix, an apolar surface that includes Ile(130) and Met(134) appears to have a direct role in G protein coupling.
引用
收藏
页码:2220 / 2228
页数:9
相关论文
共 69 条
  • [11] de Gasparo M, 2000, PHARMACOL REV, V52, P415
  • [12] Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase
    Eguchi, S
    Inagami, T
    [J]. REGULATORY PEPTIDES, 2000, 91 (1-3) : 13 - 20
  • [13] Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis
    Erlenbach, I
    Kostenis, E
    Schmidt, C
    Serradeil-Le Gal, C
    Raufaste, D
    Dumont, ME
    Pausch, MH
    Wess, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) : 29382 - 29392
  • [14] CHARACTERIZATION OF RHODOPSIN MUTANTS THAT BIND TRANSDUCIN BUT FAIL TO INDUCE GTP NUCLEOTIDE UPTAKE - CLASSIFICATION OF MUTANT PIGMENTS BY FLUORESCENCE, NUCLEOTIDE RELEASE, AND FLASH-INDUCED LIGHT-SCATTERING ASSAYS
    ERNST, OP
    HOFMANN, KP
    SAKMAR, TP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) : 10580 - 10586
  • [15] Fanelli F, 1999, PROTEINS, V37, P145, DOI 10.1002/(SICI)1097-0134(19991101)37:2<145::AID-PROT1>3.0.CO
  • [16] 2-R
  • [17] Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin
    Farrens, DL
    Altenbach, C
    Yang, K
    Hubbell, WL
    Khorana, HG
    [J]. SCIENCE, 1996, 274 (5288) : 768 - 770
  • [18] RHODOPSIN MUTANTS THAT BIND BUT FAIL TO ACTIVATE TRANSDUCIN
    FRANKE, RR
    KONIG, B
    SAKMAR, TP
    KHORANA, HG
    HOFMANN, KP
    [J]. SCIENCE, 1990, 250 (4977) : 123 - 125
  • [19] FRANKE RR, 1992, J BIOL CHEM, V267, P14767
  • [20] β-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor
    Gáborik, Z
    Szaszák, M
    Szidonya, L
    Balla, B
    Paku, S
    Catt, KJ
    Clark, AJL
    Hunyady, L
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (02) : 239 - 247